C12N 2501/113
Acidic fibroblast growth factor
Official title: Acidic fibroblast growth factor (aFGF, FGF-1)
C12N2501/113 (Acidic fibroblast growth factor) appears on 121 US grants and 223 published applications in this corpus.
Search patents in C12N- Granted patents
- 121
- Published applications
- 223
- Assignees
- 134
- Inventors
- 393
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 4 |
| 2003 | 0 | 1 |
| 2004 | 2 | 9 |
| 2005 | 2 | 8 |
| 2006 | 1 | 7 |
| 2007 | 1 | 4 |
| 2008 | 2 | 3 |
| 2009 | 2 | 5 |
| 2010 | 5 | 9 |
| 2011 | 3 | 7 |
| 2012 | 5 | 6 |
| 2013 | 4 | 4 |
| 2014 | 2 | 8 |
| 2015 | 7 | 10 |
| 2016 | 7 | 11 |
| 2017 | 9 | 14 |
| 2018 | 8 | 14 |
| 2019 | 9 | 18 |
| 2020 | 8 | 14 |
| 2021 | 7 | 10 |
| 2022 | 2 | 8 |
| 2023 | 6 | 13 |
| 2024 | 8 | 14 |
| 2025 | 8 | 12 |
| 2026 | 6 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ex vivo proliferation of epithelial cells29 Sep 2026US 12,747,425 B2Propagenix Inc.
- Stem cell-derived Schwann cells19 May 2026US 12,630,801 B2Memorial Sloan Kettering Cancer Center
- Xeno-free and transgene-free reprograming of mesenchymal stem cells toward neural progenitor cells17 Mar 2026US 12,577,532 B2Institute for Scientific Research and Technology Services (Indicasat)
- Method for isolating ureteric bud tip cells17 Mar 2026US 12,577,536 B2Kyoto University
- Method for inducing ureteric bud-like tissue3 Mar 2026US 12,565,640 B2Kyoto University
- Xeno-free and transgene-free reprograming of mesenchymal stem cells toward neural progenitor cells1 Oct 2026US 2026/0297516 A1
- Reconstructing human early embryogenesis in vitro with pluripotent stem cells1 Oct 2026US 2026/0298908 A1California Institute of Technology
- Method for neurological sialadenosis modeling and drug efficacy testing through co-culture of human salivary gland organoids and neurocytomas13 Aug 2026US 2026/0234555 A1
- Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells18 Jun 2026US 2026/0167925 A1Asterias Biotherapeutics, Inc.
- Modulation of wnt signalling in corneal disorders21 May 2026US 2026/0139018 A1
Most cited
By later US patents
- Preservation solution for ex vivo, warm preservation of tissues, explants,organs and vascular endothelial cells comprising retinal-derived fibroblast growth factor, cyclodextrin and chondroitin sulfate148US 5,599,659 ABreonics, Inc. · 1997
- Methods of producing pancreatic hormones107US 7,695,965 B2Cythera, Inc. · 2010
- Methods of producing pancreatic hormones102US 7,993,920 B2ViaCyte, Inc. · 2011
- Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction48US 6,866,842 B1University of Pittsburgh · 2005
- Assay utilizing multipotent adult stem cells39US 7,838,289 B2ABT Holding Company · 2010